| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1702.3 | 1565.2 | 1900.5 |
| Other income | 64.1 | 75.6 | 85.9 |
| Total income | 1766.4 | 1640.8 | 1986.4 |
| Profit before exceptional items & tax | 321.8 | 302.5 | 507.4 |
| Exceptional items | 0.0 | -2.0 | 0.0 |
| Profit before tax | 321.8 | 300.5 | 507.4 |
| Net profit | 244.2 | 200.2 | 400.0 |
| Operating margin | 18.2% | 18.3% | 25.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -39.00% |
|---|---|
| Net profit, quarter on quarter | +22.00% |
| Revenue, year on year | -10.40% |
| Operating profit, year on year | -38.90% |
| Operating profit, quarter on quarter | +13.60% |
BSE results filing, NSE: PIIND. Figures extracted from the filing.
PI Industries Ltd: key numbers
- Share price
- ₹2,400.00
- Market cap
- ₹36,412 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 31.3×Sector 37.5×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.
PI Industries Earnings Call: Key Takeaways
PI Industries delivered FY26 revenue of ₹67,137M with 25% EBITDA margins. Management transitioned to an innovator-led model with the launch of its first homegrown NCE, Pioxaniliprole.
PI Industries Earnings Call: Key Takeaways
PI Industries delivered a resilient FY26 despite a global agrochemical downcycle. Management is pivoting toward life sciences and electronic chemicals to de-risk from their single-molecule dependency and agrochemical volatility.